Associations Among Cardio-Ankle Vascular Index, Carotid Intima-Media Thickness, and Fibroblast Growth Factor-21

T Trakarnvanich1, S Prommool1, S Kurathong1

  • 1Renal Unit, Department of Medicine, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.

Transplantation Proceedings
|September 20, 2017
PubMed

Insights

Cardiovascular disease remains a risk after kidney transplants. Arterial stiffness (CAVI) and fibroblast growth factor-21 (FGF-21) were studied, but only CAVI showed links to carotid intima-media thickness and hemoglobin.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in chronic kidney disease (CKD) patients, persisting even post-renal transplantation.
  • Cardio-ankle vascular index (CAVI) measures arterial stiffness, while fibroblast growth factor-21 (FGF-21) may indicate atherosclerotic disease.
  • This study explored the relationship between CAVI, FGF-21, carotid intima-media thickness (IMT), and other cardiovascular risk factors in renal transplant recipients.

Purpose of the Study:

  • To investigate the association between CAVI and FGF-21 in renal transplant patients.
  • To examine the relationship of CAVI and FGF-21 with carotid intima-media thickness (IMT).
  • To assess correlations with other cardiovascular risk factors.

Main Methods:

  • The study included 90 renal transplant patients.
  • Data collected included CAVI, echocardiograms, homocysteine, high-sensitivity C-reactive protein, carotid IMT, FGF-21, and CVD incidence.
  • Statistical correlation analyses were performed.

Main Results:

  • CAVI was higher in older patients and correlated positively with carotid IMT and negatively with hemoglobin.
  • No association was found between CAVI and FGF-21 or other parameters.
  • FGF-21 correlated positively with high-sensitivity C-reactive protein and negatively with renal function.
  • Higher body mass index and carotid IMT were linked to increased cardiovascular events.

Conclusions:

  • Cardiovascular risk factors persist after renal transplantation, irrespective of arterial stiffness.
  • Close cardiac monitoring and risk-factor modification are essential post-transplantation.
  • The study highlights the ongoing need for cardiovascular surveillance in renal transplant recipients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
552
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K